Triple Immunotherapy Shows Dramatic Results
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.
Researchers are using blood samples to follow people considered at-risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
Dr. David Chang explains the Precision Panc initiative, a program through the UK’s NHS that helps pancreatic cancer patients find treatments.
Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
Dr. Anne Marie Lennon explains the CancerSEEK blood test, a liquid biopsy in clinical trials for early detection of eight cancers, including pancreatic.
If you’ve lost relatives to pancreatic cancer or have a genetic mutation tied to the disease, joining a tumor registry can help doctors identify early detection and screening options.